The clinical success of cancer immunotherapy is providing exciting opportunities for the
development of new methods to detect and treat cancer more effectively. A new generation …

T cells are often referred to as the 'guided missiles' of our immune system because of their
capacity to traffic to and accumulate at sites of infection or disease, destroy infected or …

Highlights•Biomaterials can potentially improve the safety and efficacy of cancer
immunotherapy.•Biomaterials scaffolds can program immune cell function in peripheral …

Our understanding of immunological regulation has progressed tremendously alongside the
development of materials science, and at their intersection emerges the possibility to employ …

Immunotherapy is a promising treatment modality for cancer as it can promote specific and
durable anti-cancer responses. However, limitations to current approaches remain …

Cancer immunotherapy, as a paradigm shift in cancer treatment, has recently received
tremendous attention. The active cancer vaccination, immune checkpoint blockage (ICB) …

Cancer immunotherapy has recently shown dramatic clinical success inducing durable
response in patients of a wide variety of malignancies. Further improvement of the clinical …

The immune system has remarkable capabilities to combat disease with exquisite selectivity.
This feature has enabled vaccines that provide protection for decades and, more recently …

Cancer immunotherapy has advanced significantly in recent years due to its promising
clinical outcomes in a variety of cancer malignancies and holds great promise in becoming …

Cancer immunotherapy meets biomaterials | Nature Biotechnology Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …